evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract
10215,GENE_SUMMARY,,"EZH1, an epigenetic modifier, is altered by mutation or amplification in various tumors.",,2017-03-28,,2145,EZH1,enhancer of zeste 1 polycomb repressive complex 2 subunit,False,ENST00000428826,NM_001991.3,KMT6B,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
10216,GENE_BACKGROUND,,"EZH1 is the catalytic component of the Polycomb repressive complex 2 (PRC2) which methylates histone H3 at lysine 27 (H3K27), resulting in chromatin compaction and target gene repression. Compared to its homolog, EZH2, EZH1-containing PRC2 complexes show weaker methylation activity, target fewer genes, and are more abundant in non-proliferative adult organs (PMID: 19026781). EZH1 plays a role in maintaining embryonic stem cell pluripotency (PMID: 19026780). EZH1 is not commonly altered in cancer, but recurrent mutations in EZH1 are often the second hit in autonomous thyroid adenomas (PMID: 27500488). Dual EZH1/2 inhibitors are being tested preclinically in several cancers (PMID: 24183969, 25395428).",,2017-10-18,,2145,EZH1,enhancer of zeste 1 polycomb repressive complex 2 subunit,False,ENST00000428826,NM_001991.3,KMT6B,False,27500488,Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas.,The Journal of clinical investigation,2018-09-01T20:16:00,126,9,3383-8,Calebiro D et al,doi: 10.1172/JCI84894,,0001-09-01,,19026781,Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.,Molecular cell,2017-11-21T20:08:00,32,4,503-18,Margueron R et al,doi: 10.1016/j.molcel.2008.11.004,,0001-11-21,,19026780,EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.,Molecular cell,2017-11-21T20:08:00,32,4,491-502,Shen X et al,doi: 10.1016/j.molcel.2008.10.016,,2017-11-21T05:02:00,,25395428,Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia.,Blood,2018-01-08T20:15:00,125,2,346-57,Xu B et al,doi: 10.1182/blood-2014-06-581082,,0001-01-08,,24183969,Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth.,Chemistry &amp; biology,2017-11-21T20:13:00,20,11,1329-39,Garapaty-Rao S et al,doi: 10.1016/j.chembiol.2013.09.013,,0001-11-21,
